Overcoming Challenges in Ophthalmic Formulations with Right Quality of Excipients
WEBINAR
The formulation of ophthalmic drugs must address a unique combination of requirements. In addition to ensuring quality, drug tolerability, and fostering patient compliance, formulators must also consider tonicity, viscosity, pH, stability, sterility, and microbiological purity. This webinar will address how to overcome common challenges in ophthalmic formulations with a selection of the right quality of excipients. Our GMP grade excipients are in line with ophthalmic industry standards and needs supported by our Emprove® Program. Our Emprove® Program along with the Emprove® Expert portfolio range combines comprehensive documentation with excellent service to support risk assessment and qualification for your ophthalmic process.
In this webinar, you will learn:
- Challenges in ophthalmic formulation development
- Selection of excipients for ophthalmic formulations
- Risk Mitigation in ophthalmic formulations with Emprove® Program
Speaker
Smita Rajput, Ph.D.
Merck
Field Marketing Manager
Smita Rajput is Merck's liquid formulation expert for parenterals and ophthalmics. Smita has 8 years of professional experience working across multiple roles in pharmaceutical product development. Her expertise in formulation development of injectables and ophthalmics enables her to identify and address unmet market needs. With her expertise, Smita provides consultations for the selection of excipients in the injectable and ophthalmic segment. She has a Ph.D. in pharmaceutics.
Pharma and biopharma manufacturing
- Classical pharma manufacturing
Duration:1h
Language:English
Session 1:presented September 20, 2022
To continue reading please sign in or create an account.
Don't Have An Account?